Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 10002-10008
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10002
Figure 1
Figure 1 Computed tomography enterography shows signs of inflammatory activity in patients with inflammatory bowel disease. A: Mucosal hyperenhancement, wall thickening with mural stratification (arrowheads), mesenteric fat stranding (arrows); B: Mucosal ulcerations (arrow); C: Hypervascularity of the involved mesentery (comb sign) (arrows); D: Enlarged mesenteric lymph nodes (arrowheads).
Figure 2
Figure 2 Selection of patients for the retrospective study with all the patients undergoing fecal calprotectin within 4 mo. CTE: Computed tomography enterography; IBD: inflammatory bowel disease.
Figure 3
Figure 3 Fecal calprotectin levels in patients with and without signs of active inflammatory disease in computed tomography enterography. CTE: Computed tomography enterography.